Portal de Periódicos da CAPES

Cardiac Electrophysiology and Pharmacology of Adenosine and ATP: Modulation by the Autonomic Nervous System

1987; Wiley; Volume: 27; Issue: 5 Linguagem: Inglês

10.1002/j.1552-4604.1987.tb03032.x

1552-4604

Amir Pelleg,

Cardiac electrophysiology and arrhythmias

The Journal of Clinical PharmacologyVolume 27, Issue 5 p. 366-372 Cardiac Electrophysiology and Pharmacology of Adenosine and ATP: Modulation by the Autonomic Nervous System Amir Pelleg PhD, Corresponding Author Amir Pelleg PhD Cardiovascular Division, The Lankenau Medical Research Center, Philadelphia, Pennsylvania.The Lankenau Medical Research Center, Lancaster Avenue west of City Line, Philadelphia, PA 19151.Search for more papers by this author Amir Pelleg PhD, Corresponding Author Amir Pelleg PhD Cardiovascular Division, The Lankenau Medical Research Center, Philadelphia, Pennsylvania.The Lankenau Medical Research Center, Lancaster Avenue west of City Line, Philadelphia, PA 19151.Search for more papers by this author First published: May‐June 1987 https://doi.org/10.1002/j.1552-4604.1987.tb03032.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Sollevi A: Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol (in press). 2 Berne RM: Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am J Physiol 1963; 204: 317–322. 3 Katholi RE, Whitlow PL, Hageman GR, et al: Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertension 1984; 2: 349–359. 4 Needleman P, Minkes MS, Douglas JR: Stimulation of prostaglandin bio-synthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs. Circ Res 1974; 34: 455–460. 5 Zehl U, Ritter CH, Forster W: Influence of prostaglandin upon adenosine release and of adenosine upon prostaglandin release in the isolated rabbit heart. Acta Biol Med Ger 1976; 35: K77–K82. 6 Born GUR, Haslam RJ, Golman M, et al: Comparative effectiveness of adenosine analogues as inhibitors of blood-platelet aggregation and as vasodilators in man. Nature 1965; 205: 678–680. 7 Darnall, Jr. RA: Aminophylline reduces hypoxic ventilatory depression: Possible role of adenosine. Pediatr Res 1985; 19: 706–710. 8 Eldridge FL, Millhorn DE, Kelly JP: Antagonism by theophylline of respiratory inhibition induced by adenosine. J Appl Physiol 1985; 59: 1428–1433. 9 Watt AH, Rontledge PA: Adenosine stimulates respiration in man. Br J Clin Pharmacol 1985; 20: 503–506. 10 Belardinelli L, West A, Crampton R, et al: Chronotropic and dromotropic effects of adenosine, in: RM Berne, TW Rall, R Rubio (eds): Regulatory Function of Adenosine. Boston, Martinus Nijhoff, 1983; 337–396. 11 Belhassen B, Pelleg A: Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: Clinical and experimental aspects. J Am Coll Cardiol 1986; 2: 414–424. 12 Heller LJ, Olsson RA: Inhibition of rats ventricular automaticity of adenosine. Am J Physiol 1985; 248: H907–H913. 13 Pelleg A, Mitamura, Mitsuoka T, et al: Effects of adenosine and adenosine 5′-triphosphate on ventricular escape rhythm in the canine heart. J Am Coll Cardiol 1986; 8: 1145–1151. 14 Belhassen B, Pelleg A: Adenosine triphosphate and adenosine: Perspectives in the acute management of paroxysmal supraventricular tachycardia. Clin Cardiol 1985; 8: 460–464. 15 Rubio R, Berne RM: Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance. Circ Res 1969; 25: 407–415. 16 Imai S, Riley AL, Berne RM: Effect of ischemia on adenine nucleotides in cardiac and skeletal muscle. Circ Res 1964; 15: 443–450. 17 Forrester T, Williams CA: Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. J Physiol 1977; 268: 371–390. 18 Belardinelli L, Mattos E, Berne RM: Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium. J Clin Invest 1981; 68: 195–205. 19 Welsley Welsley RC, Boykin MT, Belardinelli L: Role of adenosine as mediator of bradyarrhythmias during hypoxia in isolated guinea pig hearts. Cardiovasc Res 1986; 20: 752–759. 20 Welsley Welsley RC, Lermann BB, DiMarco JP, et al: Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: Possible role of adenosine. J Am Coll Cardiol 1986; 8: 1232–1234. 21 Shah PK, Nalos P, Peter T: Atropine resistant post infarction complete AV block: Possible role of adenosine and improvement with aminophylline. Am Heart J 1987; 113: 194–195. 22 Drury AN, Szent-Gyorgyi A: The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol (Lond) 1929; 68: 213–237. 23 Drury AN, Lutwak-Mann C, Solandt OM: The inactivation of adenosine by blood with special reference to cat's blood. Q J Exp Physiol 1938; 27: 215–236. 24 Pelleg A, Mitamura H, Michelson EL: Evidence for vagal involvement in the electrophysiologic actions of exogenous adenosine and adenosine triphosphate in the canine heart. J Auton Pharmacol 1985; 5: 207–212. 25 Rossi A, Piery Y, Kreher P: Modification par les nucleotides adenyliques de l'effet chronotrope de la stimulation du vague sur le coeur du rat. CR Soc Biol (Paris) 1967; 161: 860–861. 26 Munoz A, Leenhardt A, Sassine A, et al: Atropine antagonizes the effect of adenosine on atrioventricular conduction in closed chest dogs (abstract). Circulation 1985; 72(suppl 3): 241. 27 Puech P, Sassine A, Munoz A, et al: Electrophysiologic effects of purines: Clinical applications, in DP Zipes, J Jalife (eds): Cardiac Electrophysiology and Arrhythmias. Orlando, FL, Grune & Stratton 1986; 443–450. 28 Murthy VS, Zagar ME, Vollmer RR, et al: Pentobarbital-induced changes in vagal tone and reflex vagal activity in rabbits. Eur J Pharmacol 1982; 84: 41–50. 29 Pelleg A, Mitsuoka T, Mazgalev T, et al: Interaction of the negative chronotropic effects of adenosine and the vagus on the canine sinus node (abstract). Circulation 1985; 72(suppl 3): 248. 30 Pelleg A, Mazgalev T, Price R, et al: Adenosine modulation of vagal effects in the rabbit sino-atrial node (abstract). Fed Proc 1985; 44: 468. 31 Monteiro EC, Ribeiro JA: Influence of adenosine on heart responses to vagal nerve stimulation (abstract). Br J Pharmacol 1968; 87: 184P. 32 Hayashi E, Mori M, Yamada S, et al: Effects of purine compounds on cholinergic nerves. Specificity of adenosine and related compounds on acetylcholine release in electrically stimulated guinea pig ileum. Eur J Pharmacol 1978; 48: 297–307. 33 Gustaffson L, Hedqvist P, Fredholm BB, et al: Inhibition of acetylcholine release in guinea pig ileum by adenosine. Acta Physiol Scand 1978; 104: 469–478. 34 Shinozuka K, Cheng J-T, Hayashi E: Effects of adenosine on contractile response of circular muscle in electrically stimulated guinea pig ileum. Jpn J Pharmacol 1985; 38: 361–365. 35 Gustafsson L: Influence of adenosine on responses to vagal nerve stimulation in the anesthetized rabbit. Acta Physiol Scand 1981; 111: 263–268. 36 Ewald DA: Potentiation of postjunctional cholinergic sensitivity of rat diaphragm muscle by high energy phosphate adenine nucleotides. J Membr Biol 1976; 29: 47–65. 37 Akasu T, Hirai K, Koketsu K: Increase in acetylcholine-receptor sensitivy by adenosine triphosphate: A novel action of ATP on ACh-sensitivity. Br J Pharmacol 1981; 74: 505–507. 38 Akasu T, Koketsu K: Effect of adenosine triphosphate on the sensitivity of the nicotinic acetylcholine-receptor in the bullfrog sympathetic ganglion cell. Br J Pharmacol 1985; 84: 525–531. 39 Wu N, Armstrong I, Wagner J: Genetic evidence that chloroadenosine increases the specific activity of choline acetyltransferase in PC 12 cells via modulation of an adenosine-dependent adenylate cyclase. Neuroscience 1984; 13: 1365–1371. 40 McQueen DS, Ribeiro JA: Effect of adenosine on carotid chemoreceptor activity in the cat. Br J Pharmacol 1981; 74: 129–136. 41 Katholi RE, Whitlow PL, Hageman GR, et al: Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via renal nerves in the dog. J Hypertension 1984; 2: 349–359. 42 Fukunaga AF, Flacke VE, Bloor BC: Hypotensive effects of adenosine and adenosine triphosphate compared with sodium nitroprusside. Anesth Analg 1982; 61: 273–278. 43 Hintze TH, Belloni FL, Harrison JE, et al: Apparent reduction in baroreflex sensitivity to adenosine in conscious dogs. Am J Physiol 1985; 249: H554–H559. 44 Emmelin N, Feldberg W: Systemic effects of adenosine triphosphate. Br J Pharmacol Chemotherap 1948; 3: 273–284. 45 Wayne EJ, Goodwin JF, Stoner HB: The effect of adenosine triphosphate on the electrocardiogram of man and animals. Br Heart J 1949; 11: 55–67. 46 Cardenas M, Aceves J, Alarcon G: Efecto del acido adenosintrifosforico sobre las propiedades fisiologicas del corazon. Arch Inst Cardiol Mex 1964; 34: 485–494. 47 Pelleg A, Belhassen B, Ilia R, et al: Comparative electrophysiologic effects of ATP and adenosine in the canine heart: Influence of atropine, propranolol, vagotomy, dipyridamole and aminophylline. Am J Cardiol 1985; 55: 571–576. 48 Hugues F-C, Jan Y, Bars V, et al: Etude de l'action chronotrope de l'ATP chez l'homme. Coeur Med Inter 1980; 19: 227–234. 49 James TN: The chronotropic action of ATP and related compounds studied by direct perfusion of the sinus node. J Pharmacol Exp Ther 1965; 149: 233–247. 50 Pelleg A, Mitsuoka T, Michelson EL, et al: Evidence against P2-purinoceptor mediation of the negative chronotropic action of adenosine 5′-triphosphate in the canine sinus node in vivo (abstract). Pflugers Arch 1986; 407: S52. 51 Timour-Chah Q, Bertrix L, Lang J, et al: Enhancement by Ca2+ ions of cholinergic effects on the canine heart in situ. Arch Pharmacol 1983; 322: 59–64. 52 Silinksy EM: The biological pharmacology of calcim-dependent acetylcholine secretion. Pharmacol Rev 1985; 37: 81–132. 53 Belhassen B, Pelleg A, Shoshani D, et al: Atrial fibrillation induced by adenosine triphosphate. Am J Cardiol 1984; 54: 1405–1406. 54 Coumel P, Attuel P, Lavallee JP, et al: Syndrome d'arythmie auriculaire d'origine vagale. Arch Mal Coeur 1978; 71: 645–656. 55 Spear JF, Moore EN: Influence of brief vagal and stellate nerve stimulation on pacemaker activity and conduction within the atrioventricular conduction system of the dog. Circ Res 1973; 32: 27–41. 56 Schrader J, Baumann G, Gerlach E: Adenosine as an inhibitor of myocardial effects of catecholamines. Pflugers Arch 1977; 372: 29–35. 57 Dobson Dobson JG, Fenton RA: Antiadrenergic effects of adenosine in the hearts, in RM Berne, TW Rall, R Rubio (eds): Regulatory Function of Adenosine. Boston, Martinus Nijhoff, 1983; 363–376. 58 Dobson Dobson JG, Schrader J: Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cardiol 1984; 16: 813–822. 59 Dobson Dobson JG: Interaction between adenosine and inotropic interventions in guinea pig atria. Am J Physiol 1983; 245: H475–H480. 60 Dobson Dobson JG: Mechanism of adenosine inhibition of catecholamine-induced responses in the heart. Circ Res 1983; 52: 151–160. 61 Fenton RA, Dobson Dobson JG: Adenosine and calcium alter adrenergic-induced intact heart protein phophorylation. Am J Physiol 1984; 246: H559–H565. 62 LaMonica DA, Frohloff N, Dobson JG: Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol 1985; 248: H737–H744. 63 Dobson Dobson JG: Adenosine reduces catecholamine contractile response in oxygenated and hypoxic atria. Am J Physiol 1983; 245: H468–H474. 64 Baumann G, Schrader J, Gerlach E: Inhibitory action of adenosine on histamine-and dopamine-stimulated cardiac contractility and adenylate cyclase in guinea pigs. Circ Res 1981; 48: 259–266. 65 Hattori Y, Levi R: Adenosine selectively attenuates H2-and beta-mediated cardiac responses to histamine and norepinephrine: An unmasking of H1 and alpha-mediated selective responses. J Pharmacol Exp Ther 1984; 231: 215–223. 66 Genovese A, Levi R: Adenosine modulates histamine-induced stimulation of human atrial myocardium: Protection by H1-receptor blockade, in A Pelleg, EL Michelson, LS Dreifus (eds): Cardiac Electrophysiology and Pharmacology of Adenosine and ATP: Basic and Clinical Aspects. New York, Alan R. Liss, 1986; 345–360. 67 Samet MK, Rutledge CO: Antagonism of the positive chronotropic effect of norepinephrine by purine nucleosides in rat atria. J Pharmacol Exp Ther 1984; 232: 106–110. 68 Endoh M, Yamashita S: Adenosine antagonizes the positive inotropic action mediated via β, but not α-adrenoceptors in the rabbit papillary muscle. Eur J Pharmacol 1980; 65: 445–448. 69 Schrader J, Rubio R, Berne RM: Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: A possible effect on Ca+2 influx. J Mol Cell Cardiol 1975; 7: 427–433. 70 Rubio R, Belardinelli L, Thompson CI, et al: Cardiac adenosine: Electrophysiologic effects, possible significance in cell function, and mechanism controlling its release, in HP Baer, GI Drummond (eds): Physiological and Regulatory Functions of Adenosine and Adenine Nucleotides. New York, Raven Press, 1979; 167–182. 71 Belardinelli L, Vogel S, Linden J, et al: Antiadrenergic action of adenosine on ventricular myocardium in embryonic chick hearts. J Mol Cell Cardiol 1982; 14: 291–294. 72 Rardon DP, Bailey JC: Adenosine attenuation of the electrophysiologic effects of isoproterenol on cardiac Purkinje fibers. J Pharmacol Exp Ther 1983; 228: 792–798. 73 Belardinelli L, Isenberg G: Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 1983; 53: 287–297. 74 Bhat SV, Bajwa BS, Dornauer H, et al: Structures and stereochemistry of new lambdane diterpenoids from coleus forskohlii brig. Tetrahedron Lett 1977; 19: 1669–1672. 75 Daly JW: Forskolin adenylate cyclase and cell physiology: An overview. Adv Cycl Nucl Prot Phosphoryl Res 1984; 17: 81–89. 76 Lindner E, Dohadwalla AN, Bhattacharya BK: Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from coleus forskohlii: Forskolin. Arzneimittelforsch 1978; 28: 284–289. 77 Rodger IW, Shahid M: Forskolin, cyclic nucleotides and positive inotropism in isolated papillary muscles of the rabbit. Br J Pharmacol 1984; 81: 151–159. 78 Zafirov DH, Palmer JM, Wood JD: Adenosine inhibits forskolin-induced excitation in myentric neurons. Eur J Pharmacol 1985; 113: 143–144. 79 Fredholm BB, Jonzon B, Lindstrom K: Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices. Arch Pharmacol 1986; 332: 173–178. 80 West GA, Isenberg G, Belardinelli L: Antagonism of forskolin effects by adenosine in isolated hearts and ventricular myocytes. Am J Physiol 1986; 250: H769–H777. 81 Ui M: Islet-activating protein, pertussis toxin: A probe for functions of the inhibitory guamine nucleotide regulatory component of adenylate cyclase. Trends Pharmacol Sci 1984; 5: 277–279. 82 Endoh M, Maruyama M, Taira N: Modification by islet-activating protein of direct and indirect inhibitory actions of adenosine on rat atrial contraction in relation to cyclic nucleotide metabolism. J Cardiovasc Pharmacol 1983; 5: 131–142. 83 Endoh M, Maruyama M, Taira N: Adenosine-induced changes in rate of beating and cyclic nucleotide levels in rat atria: Modification by islet-activating protein, in Y Kuroda, JW Phillis, et al (eds): Physiology and Pharmacology of Adenosine Derivatives. New York, Raven Press, 1983; 127–141. 84 Schutz W, Tuisl E: Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. Eur J Pharmacol 1981; 76: 285–288. 85 Bohm M, Bruckner R, Hackbarth I, et al: Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart prepartions. Evidence against a cyclic AMP-and cyclic GMP-dependent effect. J Pharmacol Exp Ther 1984; 230: 483–492. 86 Bruckner R, Genner A, Wilfried M, et al: Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: Evidence against a role of cyclic AMP and cyclic GMP. J Pharmacol Exp Ther 1985; 234: 766–774. 87 Webster S, Olsson RA: Adenosine regulation of canine cardiac adenylate cyclase. Biochem Pharmacol 1981; 30: 369–373. 88 Seitelberger R, Schutz W, Schlappack O, et al: Evidence against the adenosine-catecholamine antagonism under in vivo conditions. Arch Pharmacol 1984; 325: 234–239. 89 Raberger G, Fischer G, Krumpl G, et al: Further evidence against an adenosine-catecholamine antagonism in vivo: Investigations with treadmill-exercise in dogs (abstract). Pflugers Arch 1986; 407: S16. 90 Lerman BB, Belardinelli L, DiMarco JP: Adenosine sensitive ventricular tachycardia: Evidence suggesting cyclic AMP mediated triggered activity. Circulation 1986; 74: 270–280. 91 Lerman BB, Belardinelli L: Effects of adenosine on ventricular tachycardia, in A Pelleg, EL Michelson, LS Dreifus (eds): Cardiac Electrophysiology and Pharmacology of Adenosine and ATP: Basic and Clinical Aspects. New York, Alan R Liss, 1986; 301–314. 92 Hoffman WE, Satinover I, Miletich DJ, et al: Cardiovascular changes during sodium nitroprusside or adenosine triphosphate infusion in the rat. Anesth Analg 1982; 61: 99–103. 93 Ohnishi A, Biaggioni I, Deray G, et al: Hemodynamic effects of adenosine in conscious spontaneously hypertensive and normotensive rats. Hypertension 1986; 8: 391–398. 94 Lagerkranser M, Irestedt L, Sollevi A, et al: Central and splanchnic hemodynamics in the dog during controlled hypotension with adenosine. Anesthesiology 1984; 60: 547–552. 95 Sollevi A, Lagerkranser M, Andreen M, et al: Relationship between arterial and venous adenosine levels and vasodilation during ATP-and adenosine-infusion in dogs. Acta Physiol Scand 1984; 120: 171–176. 96 Biaggioni I, Ourot J, Kincaid D, et al: Humoral and hemodynamic effects of adenosine infusion in man (abstract). Clin Res 1985; 33: 280A. 97 Ribeiro JA, McQueen DS: On the neuromuscular depression and chemoreceptor activation caused by adenosine, in JW Daly, Y Kuroda, JW Phillis, et al (eds): Physiology and Pharmacology of Adenosine. New York, Raven Press, 1983; 179–188. 98 Hall JE, Granger JP: Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs. Am J Physiol 1986; 250: F32–F39. 99 Burnstock G, Campbell G, Satchell D, et al: Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by nonadrenergic inhibitory nerves in the gut. Br J Pharmacol 1970; 40: 668–688. 100 Editorial: Purinergic nerves. Lancet 1977; 2: 1331–1332. 101 Stone TW: Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience 1981; 6: 523–555. 102 Akasu T, Shinnick-Gallagher P, Gallagher JP: Adenosine mediates slow hyperpolarizing synaptic potential in autonomic neurons. Nature 1984; 311: 62–65. 103 Ribeiro JA: Purinergic modulation of transmitter release. J Theor Biol 1979; 80: 259–270. 104 Fredholm BB, Hedqvist P: Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol 1980; 29: 1635–1643. 105 Phillis JW, Barraco RA: Adenosine, adenylate cyclase, and transmitter release. Adv Cyclic Nucl Protein Phosphor Res 1985; 19: 243–257. 106 Dunwiddie TV: The physiological role of adenosine in the central nervous system. Intl Rev Neurobiol 1985; 27: 63–132. 107 Hedqvist P, Fredholm BB: Inhibitory effect of adenosine on adrenergic neuroeffector transmission in the rabbit heart. Acta Physiol Scand 1979; 105: 120–122. 108 Lokhandwala MF: Inhibition of cardiac sympathetic neurotransmission by adenosine. Eur J Pharmacol 1979; 60: 353–357. Citing Literature Volume27, Issue5May‐June 1987Pages 366-372 ReferencesRelatedInformation